ResearcherMayo ClinicNo recent work listed
Markus Frederic Renschler
Matched on OpenAlex author ID A5066084910. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 20
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 3 papers
Papers 5
- Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study. Co-author DOI 10.1097/mpa.0000000000000742↗
- Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, et al. "A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancrea… First author DOI 10.1177/1758834017699772↗
- 18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer. Co-author DOI 10.1186/s40644-017-0125-5↗
- Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. Last author DOI 10.1056/nejmc1314761↗
- Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. Last author DOI 10.1056/nejmoa1304369↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel D. Von Hoff · 5 shared papers, 2013–2017 · strength 0.39
- Paper Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, et al. "A modified regimen of biweekly gemcitabine and nab-paclit… DOI 10.1177/1758834017699772↗
- Paper 18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer. DOI 10.1186/s40644-017-0125-5↗
- Paper Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory… DOI 10.1097/mpa.0000000000000742↗
- Ramesh K. Ramanathan · 3 shared papers, 2013–2017 · strength 0.18
- Paper 18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancer. DOI 10.1186/s40644-017-0125-5↗
- Paper Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory… DOI 10.1097/mpa.0000000000000742↗
- Paper Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. DOI 10.1056/nejmoa1304369↗
- David Goldstein · 2 shared papers, 2014–2017 · strength 0.14
- Mitesh J. Borad · 1 shared paper, 2017 · strength 0.08
- Ronald Lee Korn · 1 shared paper, 2017 · strength 0.08
- Volker Kunzmann · 1 shared paper, 2017 · strength 0.07
- David Goldstein · 1 shared paper, 2013 · strength 0.03
- Sergei Tjulandin · 1 shared paper, 2013 · strength 0.03
- Josep M. Tabernero · 1 shared paper, 2013 · strength 0.03
- Mansoor Noorali Saleh · 1 shared paper, 2013 · strength 0.03
- Marion Harris · 1 shared paper, 2013 · strength 0.03
- Manuel M. Hidalgo · 1 shared paper, 2013 · strength 0.03
- Wen Wee Ma · 1 shared paper, 2013 · strength 0.03
- Malcolm J. Moore · 1 shared paper, 2013 · strength 0.03
- Jeffrey R. Infante · 1 shared paper, 2013 · strength 0.03
- Nathan Bahary · 1 shared paper, 2013 · strength 0.03
- Michele Reni · 1 shared paper, 2013 · strength 0.03
- Eric Van Cutsem · 1 shared paper, 2013 · strength 0.03
- Elena Gabriela Chiorean · 1 shared paper, 2013 · strength 0.03
- Daniel A. Laheru · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.